Induction of homologous virus neutralizing antibodies in guinea-pigs immunized with two human immunodeficiency virus type 1 glycoprotein gp120-iscom preparations. A comparison with other adjuvant systems

Vaccine

Volumn 14, Issue 4, 1996, Pages 344-352

  Sjölander, Sigrid ^a   Hansen, John Erik S ^b   Lövgren Bengtsson, Karin ^a   Åkerblom, Lennart ^c   Morein, Bror ^a,c  

^a SWEDISH UNIVERSITY OF AGRICULTURAL SCIENCES   (Sweden)

^b HVIDOVRE HOSPITAL   (Denmark)

^c NATIONAL VETERINARY INSTITUTE   (Sweden)

Author keywords

HIV I; Iscoms; Recombinant gp120; Virus neutralization

Indexed keywords

ALUMINUM HYDROXIDE; GLYCOPROTEIN GP 120; IMMUNOLOGICAL ADJUVANT; ISCOM; MONOCLONAL ANTIBODY; QUIL A;

ANIMAL EXPERIMENT; ANTIBODY RESPONSE; ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; GUINEA PIG; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNIZATION; IMMUNOGENICITY; NONHUMAN; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION; VIRUS NEUTRALIZATION;

ADJUVANTS, IMMUNOLOGIC; AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, CD4; ENZYME-LINKED IMMUNOSORBENT ASSAY; GUINEA PIGS; HIV ANTIBODIES; HIV ENVELOPE PROTEIN GP120; HUMANS; IMMUNIZATION; ISCOMS; MOLECULAR SEQUENCE DATA; NEUTRALIZATION TESTS; PROTEIN CONFORMATION; PROTEIN DENATURATION; SAPONINS; SOLUTIONS;

EID: 0029919141     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/0264-410X(95)00163-U     Document Type: Article

References (39)

1. Dalgleish, A.G., Beverly, P.C., Clapham, P.R., Crawford, D.H., Greaves, M.F. and Weiss, R.A. The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus Nature 1984, 312, 763-767
2. Klatzmann, D.E., Champagne, E., Chamaret, S. et al. T-lymphocyte T4 molecule behave as receptor for human retrovirus LAV. Nature 1984, 312, 767-771
3. Berman, P.W., Gregory, T.J., Riddle, L. et al. Protection of chimpanzees from infection by HIV-1 after vaccination with recombinant glycoprotein gp120 but not gp160. Nature 1990, 345, 622-625
4. Girard, M., Kieny, M.-P., Pinter, A. et al. Immunization of chimpanzees confers protection against challenge with human immunodeficiency virus. Proc. Natl Acad. Sci. USA 1991, 88, 542-546
5. Putkonen, P., Björling, E., Åkerblom, L. et al. Long-standing protection of macaques against cell-free HIV-2 with a HIV-2 iscom vaccine. J. AIDS 1994, 7, 551-559
6. de Vries, P., Heeney, J.L., Boes, J. et al. Protection of rhesus macaques from SIV infection by immunization with different experimental SIV vaccines. Vaccine 1994, 12, 1443-1452
7. Cox, J.C. and Coulter, A.R. Advances in adjuvant technology and application. In: Animal Parasite Control Utilizing Biotechnology (Ed. Yong, W.K.). CRC Press Inc., NY, 1992, pp. 49-111
8. Bomford, R., Stapleton, M., Winsor, S., McKnight, A. and Andronova, T. The control of the antibody isotype response to recombinant human immunodeficiency virus gp120 antigen by adjuvants. AIDS Res. Hum. Retrovir. 1992, 8, 1765-1771
9. Haigwood, N.L., Nara, P.L., Brooks, E. et al. Native but not denatured recombinant human immunodeficiency virus type 1 gp120 generates broad-spectrum neutralizing antibodies in baboons. J. Virol. 1992, 66, 172-182
10. Pyle, S.W., Morein, B., Bess, J.W. et al. Immune response to immunostimulatory complexes (ISCOMs) prepared from human immunodeficiency virus type 1 (HIV-1) or the HIV-1 external envelope glycoprotein (gp120). Vaccine 1989, 7, 465-473
11. Åkerblom, L., Nara, P., Dunlop, N. and Morein, B. Cross-neutralizing antibodies to HIV-1 in mice after immunization with gp160 iscoms. Dissection of the immune response. AIDS Res. Hum. Retrovir. 1991, 7, 621-627
12. Haigwood, N.L., Barker, C.B., Higgins, K.W. et al. Evidence for neutralizing antibodies directed against confomational epitopes of HIV-1 gp120. In: Vaccines 90 (Eds Brown, F., Chanock, R., Ginsberg, H. and Lerner, R.). Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, 1990, pp. 313-320
13. Klinman, D.M., Steimer, K.S. and Conover, J. Comparative immunogenicity of gp120-derived proteins and their induction of anti-V3 loop region antibodies. J. AIDS 1992, 1005-1008
14. Moore, J.P. and Ho, D.D. Antibodies to discontinous of conformationally sensitive epitopes on the gp120 glycoprotein of human immunodeficiency virus type 1 are highly prevalent in sera of infected humans. J. Virol. 1993, 67, 863-875
15. Morein, B. and Simons, K. Subunit vaccines against enveloped viruses: virosomes, micelles and other protein complexes. Vaccine 1985, 3, 83-93
16. Morein, B. and Åkerblom, L. The iscom - an approach to subunit vaccines. In: Vaccines. Rational and Strategy (Ed. Isaacson, R.E.). Marcel Dekker Inc., NY, 1992, pp. 369-386
17. Takahashi, H., Takeshita, T., Morein, B., Putney, S., Germain, R.N. and Berzofsky, J. Induction of CD8+ cytotoxic T cells by immunization with purified HIV-1 envelope protein in iscoms. Nature 1990, 344, 873-875
18. Osterhaus, A., Weijrer, K., Uytdehaag, F., Jarret, O., Sundquist, B. and Morein, B. Induction of protective immune response in cats by vaccination with feline leukemia virus iscom. J. Immunol. 1985, 135, 591-596
19. Lövgren, K. and Morein, B. The requirements of lipids for the formation of immunostimulating complexes. Biotech. Appl. Biochem. 1988, 10, 161-172
20. Browning, M., Reid, G., Osborne, R. and Jarret, O. Incorporation of soluble antigens into ISCOMs: gp120 ISCOMs induce virus neutralizing antibodies. Vaccine 1992, 10, 585-590
21. Reid, G. Soluble proteins incorporate into ISCOMs after covalent attachment of fatty acid. Vaccine 1992, 10, 597-602
22. Morein, B., Ekström, J. and Lövgren, K. Increased immunogenicity of a non-amphipathic protein (BSA) after inclusion into iscoms. J. Immunol. Meth. 1990, 128, 177-181
23. Merza, M., Söber, J., Sundquist, B., Toots, I. and Morein, B. Characterization of purified gp51 from bovine leukemia virus integrated into iscom. Physiochemical properties and serum antibody response to integrated gp51. Arch. Virol. 1991, 120, 219-231
24. Bradford, M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 1976, 72, 248-254
25. Rönnberg, B., Fekadu, M. and Morein, B. Adjuvant activity of non toxic Quillaja saponaria Molina components for use in iscom-matrix. Vaccine 1995, 13, 1375-1382
26. Schutten, M., McKnight, A., Huisman, R.C. et al. Further characterization of an antigenic site of HIV-1 gp120 recognized by virus neutralizing human monoclonal antibodies. AIDS 1993, 7, 919-923
27. Neville, D.M. Molecular weight determination of proteins in SDS by gel electrophoresis in a discontinous buffer system. J. Biol. Chem. 1971, 246, 6328-6334
28. Towbin, H., Staehlin, T. and Gordon, J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: Procedure and some applications. Proc. Natl Acad. Sci. USA 1979, 76, 4350-4354
29. Arendrup, M., Sönnerborg, A., Svennerholm, B. et al. Neutralizing antibody response during human immunodeficiency virus type 1 infection: type and group specificity and viral escape. J. Gen. Virol.74, 1993 855-863
30. Hinkula, J., Gidlund, M., Persson, C., Osterhaus, A. and Wahren, B. Enzyme immunoassay (ELISA) for the evaluation of antibodies directed to the CD4 receptor-binding site of the HIV gp120 molecule. J. Immunol. Meth. 1994, 175, 37-46
31. Hansen, J.-E.S., Nielsen, C., Arendrup, M. et al. Broadly reacting antibodies targeted to mucin-typs carbohydrate epitopes of human immunodeficiency virus. J. Virol. 1991, 65, 6461-6467
32. Harada, S., Koyanagi, S. and Yamamoto, Y. Infection of HTLV-III/LAV in HTLV-1-carrying cells MT-2 and MT-4 and application in a plaque assay. Science 1985, 229, 563-566
33. Arendrup, M., Nielsen, C., Hansen, J.-E.S., Pedersen, C., Mathiesen, L. and Nielsen, J.O. Autologous HIV-1 neutralizing antibodies: emergence of neutralization-resistant escape virus and subsequent development of escape virus neutralizing antibodies. J. AIDS 1992, 5, 303-307
34. Höglund, S., Daalsgard, K., Lövgren, K., Sundquist, B., Osterhaus, A. and Morein, B. Iscoms and immunostimulation with viral antigens. In: Subcellular Biochemistry (Ed. Harris, R.J.). Plenum Press, New York, 1989, pp. 39-68
35. Leonard, C.K., Spellman, M.W., Riddle, L., Harris, R.J., Thomas, J.N. and Gregory, T.J. Assignment of intrachain disulfide bonds and characterization of potential glycosylation sites of the type 1 recombinant human immunodeficiency virus envelope glycoprotein (gp120) expressed in Chinese hamster ovary cells. J. Biol. Chem. 1990, 265, 10373-10382
36. Levy, J.A. Pathogenesis of human immunodeficiency virus infection. Microbiol. Rev. 1993, 57, 183-289
37. Lasky, L.A., Nakamura, G., Smith, D.H. et al. Delineation of region of the human immunodeficiency virus type 1 gp120 glycoprotein critical for interaction with the CD4 receptor. Cell 1987, 50, 975-985
38. Steimer, K.S., Scandella, C.J., Skiles, P.V. and Haigwood, N.L. Neutralization of divergent HIV-1 isolates by conformation-dependent human antibodies to gp120. Science 1991, 254, 105-108
39. Tilley, S.A., Honnen, W.J., Racho, M.E., Chou, T.-C. and Pinter, A. Synergistic neutralization of HIV-1 by human monoclonal antibodies against the V3 loop and the CD4-binding site of gp120. AIDS Res. Hum. Retrovir. 1992, 8, 461-467